• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	90,080	28.06.24 11:04:47	+0,210	+0,23%	90,500	90,550	90,380	89,870
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	976,600	28.06.24 09:24:09	-16,400	-1,65%	970,600	982,200	976,600	993,000